Psychometric Evaluation in Patients With Brain Damage During Neuroinflammation

Enrolling by invitationOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

July 1, 2025

Study Completion Date

June 1, 2026

Conditions
Multiple SclerosisEpilepsyParkinson DiseaseDementiaStroke
Interventions
BEHAVIORAL

Psychometric Evaluations

"The main evaluation scales we will use are the Beck Depression Inventory-II (BDI II), the State-Trait Anxiety Inventory (STAI), The twenty-item Toronto Alexithymia scale- I (TAS-20), The fatigue severity scale (FSS), Modified Fatigue Impact Scale (MFIS), The Multiple Sclerosis Impact Scale (MSIS-29), The Epworth Sleepiness Scale (ESS) (Johns MW. 1991), The Pittsburgh Sleep Quality Index (PSQ1), The Multiple Sclerosis quality of life Inventory (MSQOLI), The work productivity and activity impairment instrument (WPAI), Frailty Index.~These rating scales will be administered in person, by telephone and / or by sending them electronically."

Trial Locations (1)

86077

Ircss Neuromed, Pozzilli

All Listed Sponsors
lead

Neuromed IRCCS

OTHER